Literature DB >> 22689014

Inhibition of activation induced CD154 on CD4+ CD25- cells: a valid surrogate for human Treg suppressor function.

Danika Hill1, Nicola Eastaff-Leung, Suzanne Bresatz-Atkins, Noel Warner, Joyce Ruitenberg, Doreen Krumbiegel, Steve Pederson, Natasha McInnes, Cheryl Y Brown, Timothy Sadlon, Simon C Barry.   

Abstract

Natural Regulatory T cells (Tregs) are defined by stable expression of the cell surface proteins CD4 and CD25, low surface expression of CD127 and expression of the transcription factor FOXP3. The contribution of Treg to the prevention of autoimmunity and the maintenance of immune homoestasis is the subject of ongoing interest, as alterations in Treg numbers and function are implicated in a wide range of diseases. The in vitro benchmark for determining Treg function is suppression of proliferation of unmatched effector T cells in a mixed lymphocyte reaction (MLR) over a 3-6-day time period. As an alternative to this assay, we show that a 7-h CD154 expression assay is rapid, simple and provides a reliable readout of suppressor function. Using multiple Treg-like cell types including natural (n)Treg, inducible (i)Treg and Treg cell lines, we show that suppression of CD154 expression is a surrogate for suppression of proliferation. We propose this as a suitable alternative to the MLR assay, as it is rapid and may be more amenable to high-throughput screening, analysing large cohorts of clinical samples or assaying transiently suppressive populations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22689014     DOI: 10.1038/icb.2012.18

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  5 in total

1.  A novel method for assaying human regulatory T cell direct suppression of B cell effector function.

Authors:  Elizabeth Weingartner; Jean-Paul Courneya; Achsah Keegan; Amit Golding
Journal:  J Immunol Methods       Date:  2016-11-13       Impact factor: 2.303

2.  Operational tolerance in intestinal transplantation.

Authors:  Alexander Kroemer; Khalid Khan; Stuart S Kaufman; Jiman Kang; Joshua Weiner; Anju Duttargi; Leonid Belyayev; Chethan Ashokkumar; Rakesh Sindhi; Olga A Timofeeva; Michael Zasloff; Cal S Matsumoto; Thomas M Fishbein
Journal:  Am J Transplant       Date:  2020-08-30       Impact factor: 8.086

Review 3.  Therapeutic Potential of Regulatory T Cells in Preeclampsia-Opportunities and Challenges.

Authors:  Sarah A Robertson; Ella S Green; Alison S Care; Lachlan M Moldenhauer; Jelmer R Prins; M Louise Hull; Simon C Barry; Gustaaf Dekker
Journal:  Front Immunol       Date:  2019-03-21       Impact factor: 7.561

4.  Reduced Numbers and Impaired Function of Regulatory T Cells in Peripheral Blood of Ischemic Stroke Patients.

Authors:  Johanna Ruhnau; Juliane Schulze; Bettina von Sarnowski; Marie Heinrich; Sönke Langner; Christian Pötschke; Anika Wilden; Christof Kessler; Barbara M Bröker; Antje Vogelgesang; Alexander Dressel
Journal:  Mediators Inflamm       Date:  2016-03-17       Impact factor: 4.711

5.  Dawn of Monitoring Regulatory T Cells in (Pre-)clinical Studies: Their Relevance Is Slowly Recognised.

Authors:  A Charlotte M T de Wolf; Carla A Herberts; Marcel H N Hoefnagel
Journal:  Front Med (Lausanne)       Date:  2020-04-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.